AI
HIMSS23
Dr. John Showalter, CPO at Linus Health, describes drug therapy advances for Alzheimer's and how technology can help screen and identify at-risk patients sooner to optimize outcomes and quality of life.
HIMSS23
Kathy D. Ford, chief product and strategy officer at Project Rōnin, explains how AI can help drive value-based care for oncology by empowering clinicians to find the most effective, cost-efficient treatment for each patient.
Also, Indian healthcare SaaS platform THB has snapped up $20 million funding.
Also, HeraMED is deploying its remote pregnancy monitoring solutions in a private practice in Perth.
The startup plans to use AI-backed retinal imaging to find early signs of disease based on tech from Australian company Eyetelligence.
HIMSS23
Lee Kim, senior principal of cybersecurity and privacy at HIMSS, offers insights on the need for continuing cybersecurity training for health IT teams, staffing shortages and the potential of generative AI tools.
HIMSS23
Toby Eadelman, CTO at AvaSure, discusses how AvaSure's digital offerings can help hospitals optimize their on-site acute-care nurses' workflows amid staffing challenges.
Also, online pharmacy MedEasy has acquired its competitor in Bangladesh.
HIMSS23
Caregility COO and president Mike Brandofino says that artificial intelligence is enhancing hybrid care by connecting platforms.
Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.